跳至主要内容
临床试验/NCT02844829
NCT02844829Unknown不适用

Improved Prostate Cancer Diagnosis - Combination of Rapid Prebiopsy Magnetic Resonance Imaging and Biomarkers

Turku University Hospital1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2016年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
200
试验地点
1
主要终点
Sensitivity, specificity and accuracy of MRI and DWI at 3T magnetic field for the detection of prostate cancer in correlation with systematic TRUS guided biopsy

研究概览

简要总结

This study will enroll 200 men with clinical suspicion of prostate cancer due to higher serum level of PSA than 2.5 ng/ml or abnormal digital rectal examination.

Anatomical magnetic resonance imaging (MRI) and diffusion weighted imaging (DWI) at 3 Tesla (T) magnetic field using surface coils will be used to non-invasively predict the presence or absence of prostate cancer.

Targeted TRUS guided biopsy based on MRI findings will be performed in addition to routine twelve core TRUS biopsy.

Moreover, selected serum and urine biomarkers as well as biomarkers extracted from fresh biopsy sample will be collected and correlated with the presence or absence of prostate cancer.

详细描述

Specific aims of the current study are as follows:

i) To determine the sensitivity, specificity and accuracy of a novel rapid anatomical MRI and DWI at 3T magnetic field for the detection of prostate cancer in correlation with systematic TRUS guided biopsy

ii) To determine the sensitivity, specificity and accuracy of selected serum, urine and tissue biomarkers for detection of prostate cancer

iii) To develop statistical model for diagnosis of prostate cancer incorporating findings of a novel rapid MRI/DWI and selected biomarkers

iv) To assess the applicability of TRUS guided prostate biopsy based on MRI finding in patient with no previous prostate biopsy

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
40 Years 至 85 Years(Adult, Older Adult)
性别
Male
接受健康志愿者
否

入选标准

  • •Age: 40 to 85 years
  • •Language spoken: Finnish
  • •Clinical suspicion of prostate cancer, based on: serum level of PSA from 2,5 ng/ml to 25 ng/ml in two following measurements and/or abnormal digital rectal examination
  • •Mental status: Patients must be able to understand the meaning of the study
  • •Informed consent: The patient must sign the appropriate Ethics Committee (EC) approved informed consent documents in the presence of the designated staff

排除标准

  • •previous prostate biopsies
  • •previous diagnosis of prostate carcinoma
  • •previous prostate surgeries, e.g. TURP (transurethral prostatic resection)
  • •symptomatic of acute prostatitis
  • •contraindications for MRI (cardiac pacemaker, intracranial clips etc)
  • •uncontrolled serious infection
  • •claustrophobia
  • •any other conditions that might compromise patients safety, based on the clinical judgment of the responsible urologist

研究组 & 干预措施

MRI and biomarkers

Other

Prostate MRI. Blood and urine biomarkers. Both prior to biopsy. Tissue samples during prostatectomy.

干预措施: Prostate MRI (Other)

结局指标

主要结局

Sensitivity, specificity and accuracy of MRI and DWI at 3T magnetic field for the detection of prostate cancer in correlation with systematic TRUS guided biopsy

时间窗: Baseline (MRI prior to prostate biopsy)

次要结局

  • Sensitivity, specificity and accuracy of selected serum, urine and tissue biomarkers for detection of prostate cancer(Baseline and during procedure)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Hannu Aronen

Professor, Chief Physician

Turku University Hospital

研究点 (1)

Loading locations...

相似试验